Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federal melamine indictments

This article was originally published in The Tan Sheet

Executive Summary

ChemNutra and its owners face federal charges related to importing wheat gluten products contaminated with melamine, FDA says Feb. 6. Las Vegas-based ChemNutra, which buys ingredients from China to sell to U.S. companies, and owners Sally Qing Miller and Stephen S. Miller were charged in a 27-count indictment. Starting in March 2007, melamine was found in wheat gluten and rice protein concentrates that were linked to the deaths of pets and led to the recall of pet food products (1"The Tan Sheet" Sept. 10, 2007, p. 5). Also charged in a separate but related, 26-count indictment are Xuzhou Anying Biologic Technology Development Co., LTD., and the owner, Mao Linzhun; and Suzhou Textiles, Silk, Light Industrial Products, Arts and Crafts I/E Co., LTD., and its president, Chen Zhen Hao. Under the indictments, all defendants face charges including conspiracy to defraud customers and the introduction of a misbranded food into interstate commerce, FDA says. In a same-day statement, the Millers deny the allegations and while they acknowledge one felony count alleges they sought to defraud customers, they stress the government does not allege they "had any knowledge of the presence of melamine or any other erroneous substance"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel